Literature DB >> 14732714

The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity: probing the role of the methionine-turn in the metzincin metalloprotease superfamily.

Georgina S Butler1, Eric M Tam, Christopher M Overall.   

Abstract

Matrix metalloproteinases (MMPs) are an important family of extracellular proteases that process a variety of biologically significant molecules. MMPs are members of the metzincin superfamily of >770 zinc endopeptidases, which includes astacins, serralysins, adamalysins, leishmanolysins, and snapalysins. Metzincins are characterized by an absolutely conserved methionine residue COOH-terminal to the third histidine in the consensus sequence HEXXHXXGXX(H/D), where the histidine residues chelate a catalytic zinc ion. The canonical methionine is part of a tight 1,4-beta-turn that loops the polypeptide chain beneath the catalytic zinc ion, forming a hydrophobic floor to the Zn(2+) ion binding site. The role of this methionine is uncertain, but its absolute conservation indicates an essential catalytic or structural function. To investigate this hypothesis, we replaced Met-392 that forms the Met-turn of human MMP-2 (gelatinase A) by site-directed mutagenesis. The catalytic competence of leucine and serine mutants was assessed. (M392L)MMP-2 and (M392S)MMP-2 cleaved the physiological substrates gelatin, native type I collagen, and the chemokine monocyte chemoattractant protein-3 with similar efficiency to wild-type MMP-2. These mutants also cleaved two quenched fluorescent peptide substrates with a k(cat)/K(m) comparable to wild-type MMP-2 and underwent 4-aminophenylmercuric acetate-induced autoactivation with similar kinetics. (M392L)MMP-2 and (M392S)MMP-2 were inhibited by tissue inhibitor of metalloproteinases (TIMP)-1, -2, and -4 and by the zinc chelators 1,10-phenanthroline and a synthetic hydroxamate inhibitor, Batimastat, similar to the wild-type protein, indicating an unaltered active site topography. A tryptic susceptibility assay also suggested that (M392L)MMP-2 and (M392S)MMP-2 were correctly folded. These results challenge the dogma that this methionine residue and the Met-turn, which are absolutely conserved in all of the subfamilies of the metzincins, play an essential role in catalysis or active site structure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732714     DOI: 10.1074/jbc.M312727200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Methanethiol Binding Strengths and Deprotonation Energies in Zn(II)-Imidazole Complexes from M05-2X and MP2 Theories: Coordination Number and Geometry Influences Relevant to Zinc Enzymes.

Authors:  Douglas P Linder; Kenton R Rodgers
Journal:  J Phys Chem B       Date:  2015-09-04       Impact factor: 2.991

2.  Catalytic domain architecture of metzincin metalloproteases.

Authors:  F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2009-02-05       Impact factor: 5.157

3.  On the relevance of the Met-turn methionine in metzincins.

Authors:  Cynthia Tallant; Raquel García-Castellanos; Ulrich Baumann; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2010-03-04       Impact factor: 5.157

Review 4.  Architecture and function of metallopeptidase catalytic domains.

Authors:  Núria Cerdà-Costa; Francesc Xavier Gomis-Rüth
Journal:  Protein Sci       Date:  2014-02       Impact factor: 6.725

5.  Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products.

Authors:  Oded Kleifeld; Alain Doucet; Ulrich auf dem Keller; Anna Prudova; Oliver Schilling; Rajesh K Kainthan; Amanda E Starr; Leonard J Foster; Jayachandran N Kizhakkedathu; Christopher M Overall
Journal:  Nat Biotechnol       Date:  2010-03-07       Impact factor: 54.908

6.  A statistics-based platform for quantitative N-terminome analysis and identification of protease cleavage products.

Authors:  Ulrich auf dem Keller; Anna Prudova; Magda Gioia; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

7.  Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics.

Authors:  Anna Prudova; Ulrich auf dem Keller; Georgina S Butler; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2010-03-20       Impact factor: 5.911

8.  Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.

Authors:  Georgina S Butler; Richard A Dean; Eric M Tam; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2008-05-27       Impact factor: 4.272

9.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

10.  Biochemical characterization and N-terminomics analysis of leukolysin, the membrane-type 6 matrix metalloprotease (MMP25): chemokine and vimentin cleavages enhance cell migration and macrophage phagocytic activities.

Authors:  Amanda E Starr; Caroline L Bellac; Antoine Dufour; Verena Goebeler; Christopher M Overall
Journal:  J Biol Chem       Date:  2012-02-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.